Definium Therapeutics Inc

Financials

Cash from operating activities -45.82 M-50.14 M-64.36 M-79.13 M-131.56 M -131.56 M Cash from investing activities -297 K-297 K——-151.61 M -151.61 M Cash from financing activities 98.82 M59.05 M21.85 M253.2 M267.27 M 267.27 M Free cash flow -45.82 M-50.14 M-64.36 M-79.13 M-131.56 M -131.56 M

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.